nominally significantP < 0.05
All discovery SNP-CpG associations ( n = 497,689) were nominally significant at baseline ( P < 0.05), and 99.5% ( n = 497,443) were nominally significant during the course of the disease ( P < 0.05).
All discovery SNP-CpG associations ( n = 497,689) were nominally significant at baseline ( P < 0.05), and 99.5% ( n = 497,443) were nominally significant during the course of the disease ( P < 0.05).